13F filer · CIK 1964437
Saturn V Capital Management LP
AUSTIN, TX · filing since Q4 2022 · last filing Aug 14, 2026
Reported value
$697.5M
+$145.2M vs prior
Positions
23
New / sold out
3 / 1
Added / reduced
13 / 6
Turnover
8.1%
buys $95.5M · sells $50.6M
Top-10 weight
75.6%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | TREVI THERAPEUTICS INC | +1,052,043 | – | +$19.6M |
| New | SAGIMET BIOSCIENCES INC | +1,479,918 | – | +$11.4M |
| Added | IMMIX BIOPHARMA INC | +964,844 | +26.1% | +$9.9M |
| Added | CELCUITY INC | +88,414 | +31.4% | +$9.2M |
| Added | ZURA BIO LTD | +1,361,159 | +184.0% | +$8.0M |
| New | VIR BIOTECHNOLOGY INC | +770,643 | – | +$7.9M |
| Added | DISC MEDICINE INC | +74,804 | +16.6% | +$5.5M |
| Added | AMYLYX PHARMACEUTICALS INC | +274,216 | +6.3% | +$4.9M |
| Added | CANDEL THERAPEUTICS INC | +407,098 | +14.1% | +$4.2M |
| Added | PHARVARIS N V | +112,720 | +9.4% | +$3.9M |
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | COGENT BIOSCIENCES INC | -626,635 | -100.0% | $-24.1M |
| Reduced | OVID THERAPEUTICS INC | -3,503,606 | -84.1% | $-9.4M |
| Reduced | ALUMIS INC | -286,632 | -9.0% | $-8.1M |
| Reduced | ABIVAX SA | -23,831 | -4.4% | $-3.2M |
| Reduced | MONOPAR THERAPEUTICS INC | -33,650 | -9.7% | $-3.1M |
| Reduced | INVIVYD INC | -2,556,796 | -23.4% | $-2.2M |
| Reduced | JAZZ PHARMACEUTICALS PLC | -2,023 | -1.2% | $-487.5K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | AMYLYX PHARMACEUTICALS INCCOM | 4,624,101 | $83.0M | 11.91% |
| 2 | ALUMIS INCCOM | 2,915,443 | $82.0M | 11.76% |
| 3 | ABIVAX SASPONSORED ADS | 518,865 | $69.1M | 9.91% |
| 4 | VAXCYTE INCCOM | 852,914 | $49.6M | 7.11% |
| 5 | IMMIX BIOPHARMA INCCOM | 4,658,429 | $48.0M | 6.89% |
| 6 | PHARVARIS N VCOM | 1,314,122 | $45.4M | 6.52% |
| 7 | JAZZ PHARMACEUTICALS PLCSHS USD | 160,938 | $38.8M | 5.56% |
| 8 | CELCUITY INCCOM | 370,318 | $38.7M | 5.55% |
| 9 | DISC MEDICINE INCCOM | 524,730 | $38.4M | 5.50% |
| 10 | CANDEL THERAPEUTICS INCCOM | 3,303,686 | $34.0M | 4.88% |
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.